Khulud Alhazmi | Medicine and Health Sciences | Innovative Research Award

Published on by Computer Scientists Awards

Innovative Research Award

Khulud Alhazmi
Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Saudi Arabia.

Khulud Alhazmi
Affiliation Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University
Country Saudi Arabia
Scopus ID 57224867322
Documents 21
Citations 216
h-index 8
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0009-0001-3980-1177

Khulud Alhazmi is a researcher specializing in microbiology, infectious diseases, antimicrobial resistance, and public health. Her scholarly work emphasizes clinically significant bacterial pathogens, diagnostic microbiology, infection prevention, antimicrobial stewardship, and healthcare worker awareness of emerging infectious diseases. Through peer-reviewed publications and collaborative investigations, her research contributes to evidence-based clinical practice and healthcare policy development.[1]

Abstract

This article summarizes the academic profile of Khulud Alhazmi in recognition of contributions to microbiology and infectious disease research. Her publications examine antimicrobial resistance, diagnostic laboratory methodologies, healthcare-associated infections, and emerging viral diseases. The combination of laboratory investigations and public health studies reflects an interdisciplinary approach that supports improved clinical decision-making and infection control practices within healthcare environments.[2]

Keywords

  • Microbiology
  • Antimicrobial Resistance
  • Healthcare Epidemiology
  • Diagnostic Microbiology
  • Medicine and Health Sciences

Introduction

Modern infectious disease research requires continuous monitoring of resistant pathogens, rapid diagnostic technologies, and public health preparedness. Khulud Alhazmi’s academic work addresses these priorities through studies that investigate bacterial resistance mechanisms, healthcare worker knowledge, and laboratory innovations. Her publications provide clinically relevant information supporting evidence-based healthcare management and improved patient safety.[3]

Research Profile

According to the provided academic metrics, the researcher has produced 21 indexed publications with 216 citations and an h-index of 8. These indicators demonstrate sustained scholarly productivity and measurable scientific influence within medicine and health sciences. Research collaborations focus on clinically important microorganisms, antimicrobial therapies, diagnostic optimization, and epidemiological surveillance.[4]

Research Contributions

  • Investigation of multidrug-resistant bacterial pathogens.
  • Evaluation of diagnostic screening methodologies.
  • Studies addressing healthcare worker awareness and vaccination acceptance.
  • Reviews of antimicrobial treatment strategies and biofilm-associated infections.

Publications

  1. The Willingness of Healthcare Workers in Makkah, Saudi Arabia, to Be Vaccinated Against Monkeypox and Their Knowledge About Monkeypox (Vaccines, 2026).
  2. Hypervirulent and Drug-Resistant Klebsiella pneumoniae: Clinical Challenges and Alternative Treatment Strategies.
  3. Balancing Diagnostic Sensitivity and Operational Efficiency in MRSA Screening Using GeneXpert.
  4. A Review of Vancomycin Role in Gram Positive Biofilm-Associated Infections.

Research Impact

The published research contributes to improved understanding of antimicrobial resistance, healthcare-associated infections, and infectious disease preparedness. By integrating laboratory science with public health perspectives, these studies provide practical evidence supporting infection prevention strategies, optimized diagnostics, and informed clinical interventions. Such work is relevant for healthcare institutions seeking improved patient outcomes and enhanced epidemiological surveillance.[5]

Award Suitability

The research profile demonstrates consistent publication activity, meaningful citation performance, and contributions addressing important healthcare challenges. The combination of original investigations, clinical reviews, and public health studies reflects a balanced academic portfolio suitable for consideration within an Innovative Research Award evaluation framework based on scholarly merit, scientific relevance, and research impact.[6]

Conclusion

Khulud Alhazmi has established a focused research portfolio centered on microbiology, antimicrobial resistance, infectious disease epidemiology, and diagnostic innovation. Her published work supports clinical practice, strengthens healthcare knowledge, and contributes to the advancement of medicine and health sciences through evidence-based research and interdisciplinary collaboration.

External Links

References

  1. Vaccines. The Willingness of Healthcare Workers in Makkah, Saudi Arabia, to Be Vaccinated Against Monkeypox and Their Knowledge About Monkeypox. 10.3390/vaccines14070603.
  2. International Journal of General Medicine. Hypervirulent and Drug-Resistant Klebsiella pneumoniae.
    10.2147/IJGM.S548733.
  3. Journal of King Abdulaziz University: Medical Sciences. Balancing Diagnostic Sensitivity and Operational Efficiency in MRSA Screening Using GeneXpert. Journal Link.
  4. Therapeutics and Clinical Risk Management. Vancomycin Role in Gram Positive Biofilm-Associated Infections.
    10.2147/TCRM.S541780.
  5. Scopus Author Metrics. Research profile for Scopus Author ID 57224867322.
    https://www.scopus.com/authid/detail.uri?authorId=57224867322
  6. Computer Scientists Awards. Award evaluation framework and academic recognition information.

Anna Iwan | Medicine | Research Excellence Award

Published on by Computer Scientists Awards

Dr. Anna Iwan | Medicine | Research Excellence Award

University Clinical Hospital No.4 | Poland

Dr. Anna Iwan is a dedicated clinical oncology and internal medicine specialist with a strong focus on patient-centered cancer care, emergency medicine, and interdisciplinary clinical practice. Her professional work reflects continuous advancement in oncology treatment approaches, particularly in gynecological oncology and radiotherapy, combined with a commitment to improving patient outcomes through compassionate care and effective communication. She demonstrates strong teamwork, clinical decision-making, and empathetic patient management. Although primarily focused on clinical practice, her research visibility across Scopus and Google Scholar remains limited, with minimal indexed publications, resulting in currently low citation counts, document records, and an emerging h-index, indicating potential for future academic and research contributions.

View ORCID Profile

Featured Publications

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.